2005
DOI: 10.3201/eid1106.050222
|View full text |Cite
|
Sign up to set email alerts
|

Emergence and Spread ofStreptococcus pneumoniaewitherm(B) andmef(A) Resistance

Abstract: Streptococcus pneumoniae isolates (N = 31,001) were collected from patients with community-acquired respiratory tract infections during the PROTEKT US surveillance study (2000–2003). While the macrolide (erythromycin) resistance rate remained stable at ≈29%, the prevalence of resistant isolates containing both erm(B) and mef(A) increased from 9.7% in year 1 to 16.4% in year 3, with substantial regional variability. Almost all (99.2%) dual erm(B)+mef(A) macrolide-resistant isolates exhibited multidrug resistanc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

12
100
1
1

Year Published

2006
2006
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 110 publications
(114 citation statements)
references
References 37 publications
12
100
1
1
Order By: Relevance
“…In Germany, Bley et al (18) reported the presence of combined erm (B)+mef (A) genotype in 4.1% of pneumococcal isolates. Similar results have been increasingly reported in North America, South Asia and South Africa during the last decade (17,19). In Russia, dual resistance genes among isolates collected between 2003 and 2005 were found in 30.3% (20).…”
Section: Discussionsupporting
confidence: 74%
See 1 more Smart Citation
“…In Germany, Bley et al (18) reported the presence of combined erm (B)+mef (A) genotype in 4.1% of pneumococcal isolates. Similar results have been increasingly reported in North America, South Asia and South Africa during the last decade (17,19). In Russia, dual resistance genes among isolates collected between 2003 and 2005 were found in 30.3% (20).…”
Section: Discussionsupporting
confidence: 74%
“…Although Telli et al (16) reported higher percentages (40%) in 2007-2009, the macrolide resistance rate in this study was 22.5%, which is similar to the result of EARRSS, but higher than the rates reported previously in our hospital (13,14). S2 S3 S11 S13 S18 S6 S15 S16 S17 S4 0.1 0.2 (17). In Germany, Bley et al (18) reported the presence of combined erm (B)+mef (A) genotype in 4.1% of pneumococcal isolates.…”
Section: Discussioncontrasting
confidence: 46%
“…Three of these isolates had very high levels of resistance to beta-lactam antibiotics (MICs of 8 g/ml for both penicillin and amoxicillin). It will be interesting to determine whether these multiresistant isolates carry both ermB and mefA determinants, as do other strains closely related to Taiwan 19F -14 that were recently characterized in a global study of community-acquired respiratory tract infections (10).…”
Section: Resultsmentioning
confidence: 99%
“…People infected with an antibiotic-resistant organism are more likely to have longer hospital stays and require treatment with second-or third-line drugs that may be less effective, more toxic and more expensive (Farrell et al, 2005;Levy, 2005).…”
Section: Introductionmentioning
confidence: 99%